(Q36268319)

13 August 2017

1 reference

title

Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds (English)

1 reference

13 August 2017

0 references

1

Henry Lai

1 reference

13 August 2017

Tomikazu Sasaki

2

1 reference

PubMed ID

16185154

13 August 2017

Narendra P Singh

series ordinal

3

1 reference

PubMed ID

16185154

13 August 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

Expert Opinion on Therapeutic Targets

13 August 2017

1 reference

13 August 2017

9

1 reference

13 August 2017

5

1 reference

13 August 2017

995-1007

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

13 August 2017

1 reference

Qinghaosu (artemisinin): an antimalarial drug from China

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Artemisinins target the SERCA of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Current status of artemisinin and its derivatives as antimalarial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Pharmacokinetics of artemisinin-type compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

An Over Four Millennium Story Behind Qinghaosu (Artemisinin)-A Fantastic Antimalarial Drug from a Traditional Chinese Herb

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

A medicinal chemistry perspective on artemisinin and related endoperoxides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Identification of an antimalarial synthetic trioxolane drug development candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Progress in the research of artemisinin-related antimalarials: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

The iron metabolism of neoplastic cells: alterations that facilitate proliferation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Transferrin receptor: its biological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

In vitro tumor growth inhibition by bispecific antibodies to human transferrin receptor and tumor-associated antigens is augmented by the iron chelator deferoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Morphological, immunocytochemical and growth characteristics of three human glioblastomas established in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Receptor-mediated endocytosis of a manganese complex of transferrin into neuroblastoma (SHSY5Y) cells in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Trophic factors and central nervous system metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Transferrin receptor 2 protein is not expressed in normal erythroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

A rapid and efficient microtechnique for the analysis of functional transferrin receptors on tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Characterization of the anti-cancer activity of transferrin-adriamycin conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10beta-(2-hydroxyethyl)deoxoartemisinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Inhibition of glutathione S-transferases by antimalarial drugs possible implications for circumventing anticancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Antimalarial, antiproliferative, and antitumor activities of artemisinin-derived, chemically robust, trioxane dimers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562/adr and GLC4/adr resistant cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Synthesis and cytotoxicity of artemisinin derivatives containing cyanoarylmethyl group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Artesunate reduces chicken chorioallantoic membrane neovascularisation and exhibits antiangiogenic and apoptotic activity on human microvascular dermal endothelial cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Antimalarial dihydroartemisinin also inhibits angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

TNP-470 inhibits 7,12-dimethylbenz[a]anthracene-induced mammary tumor formation when administered before the formation of carcinoma in situ but is not additive with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Synthesis and antiangiogenic activity of thioacetal artemisinin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

The Antimalaria Agent Artemisinin Exerts Antiangiogenic Effects in Mouse Embryonic Stem Cell-Derived Embryoid Bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Synthesis of O-aminodihydroartemisinin via TMS triflate catalyzed C-O coupling reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Apoptosis-based drug screening and detection of selective toxicity to cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Potent inhibition of angiogenesis and liver tumor growth by administration of an aerosol containing a transferrin-liposome-endostatin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Transferrin/transferrin receptor-mediated drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Synthesis of chlorin e6-transferrin and demonstration of its light-dependent in vitro breast cancer cell killing ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Artemisinin: mechanisms of action, resistance and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Antimicrobial resistance: the example of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Bacterial solutions to the iron-supply problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Iron uptake mechanisms and their regulation in pathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Transferrin-iron uptake by Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Acquisition of siderophores in gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

21 January 2018

Microbial iron transport

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Bacterial transferrin and lactoferrin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Iron uptake and increased intracellular enzyme activity follow host lactoferrin binding by Trichomonas vaginalis receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Syntheses and studies of multiwarhead siderophore-5-fluorouridine conjugates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Molecular mechanisms of iron uptake in fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

Microbial iron chelators as drug delivery agents: the rational design and synthesis of siderophore-drug conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

NMR Studies on Novel Antitumor Drug Candidates, Deoxoartemisinin and Carboxypropyldeoxoartemisinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.995

21 January 2018

Identifiers

DOI

10.1517/14728222.9.5.995

1 reference

13 August 2017

1 reference

PubMed ID

16185154